SCIENTIFIC COMMITTEE
CORE FACULTY
J. Ambler, Wockhardt Pharmaceuticals, USA
D. Andes, University of Wisconsin, USA
H. Boucher, Tufts Medical Center, USA
S. Brisse, Institut Pasteur, France
E. Brown, McMaster University, Canada
G. Challis, University of Warwick, UK
J.-P. Charrier, bioMérieux, France
J.-F. Collet, Université de Louvain, Belgique
P. Courvalin, Institut Pasteur, France
G. Cox, University of Guelph, Canada
L. Debarbieux, Institut Pasteur, France
J.D. Docquier, University of Sienna, Italy
L. Doubovetzky, Sanofi, France
E. Duffy, CARB-X, USA
F. Fang, University of Washington USA
M. Fisher, St Georges University, UK
M. Gilmore, Harvard Medical School, USA
L. Hall-Stoodley, Ohio State University, USA
D. Hughes, Uppsala University, Sweden
M. de Kraker, Hôpitaux de Genève, Switzerland
S. Lahiri, Boehringer Ingelheim, USA
F. Lebreton, Harvard Medical School, USA
M. Lipsitch, Harvard Medical School, USA
S. Lory, Harvard Medical School, USA
B. Luisi, University of Cambridge, UK
A. Mankin, University of Illinois, USA
H. Moser, Novartis, USA
R. Mueller, Helmoltz-Institute, Germany
A. Myers, Harvard University, USA
E. Pamer, Memorial Sloan Kettering Cancer Center, USA
K. Papp-Wallace, Case Western Reserve U., USA
M. Pinho, Universidad Nova de Lisboa, Portugal
S. Projan, Arsanis Inc, USA
M. Pucci, Spero Therapeutics, USA
J. Rex, F2G, UK
H.-G. Sahl, University of Bonn, Germany
M.-W. Tan, Genentech/Roche, USA
U. Theuretzbacher, CAIA, Austria
M. Vazquez-Laslop, University of Illinois, USA
G. Wright, McMaster University, Canada